logo
ResearchBunny Logo
Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus

Medicine and Health

Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus

A. A. Weil, K. G. Luiten, et al.

This study, conducted by a team of researchers including Ana A Weil and Kyle G Luiten, reveals how genomic surveillance on a university campus tracked the rapid surge of the SARS-CoV-2 Omicron variant, highlighting crucial differences in infection dynamics compared to Delta variants. Discover the vital role this research plays in shaping public health responses amidst the pandemic.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Related Publications

Explore these studies to deepen your understanding of the subject.

Human antibodies to SARS-CoV-2 with a recurring YYDRXG motif retain binding and neutralization to variants of concern including Omicron
Medicine and Health

Human antibodies to SARS-CoV-2 with a recurring YYDRXG motif retain binding and neutralization to variants of concern including Omicron

H. Liu, C. I. Kaku, et al.

SARS-CoV-2 genomic surveillance in wastewater as a model for monitoring evolution of endemic viruses
Medicine and Health

SARS-CoV-2 genomic surveillance in wastewater as a model for monitoring evolution of endemic viruses

M. Yousif, S. Rachida, et al.

A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration
Medicine and Health

A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration

H. Ma, X. Zhang, et al.

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)
Medicine and Health

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)

A. L. Koen, A. Izu, et al.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny